(EMAILWIRE.COM, July 24, 2019 ) Continuous manufacturing in pharmaceutical processes such as cost-effectiveness and improved efficiency of manufacturing, favorable regulatory environment, and support from regulatory authorities for the implementation of continuous manufacturing.

The global continuous manufacturing market is expected to reach USD 650.4 Million by 2022 from USD 348.5 Million in 2017, at a CAGR of 13.3%.

Market Dynamics

+ Drivers

+ Cost-Effective Approach for Pharmaceutical Manufacturing
+ Better Efficiency of Manufacturing Operations Offered By Continuous Processes
+ Support From Regulatory Authorities for the Implementation of Continuous Manufacturing


Request for Free Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=84747779

The Continuous Manufacturing market is segmented on the basis of product, application, end user, and geography. The product segment includes integrated systems, semi-continuous systems, and controls. The integrated systems segment is expected to account for the largest share of the Continuous Manufacturing market in 2017. The integrated systems enable end-to-end manufacturing to convert raw materials into final products. In addition, these systems save substantial cost and time by integrating various pharmaceutical processes in a single system.

The application segment of the Continuous Manufacturing market includes active pharmaceutical ingredient (API) manufacturing and end product manufacturing. The end product manufacturing segment is further categorized as solid dosage manufacturing and liquid dosage manufacturing. The end product manufacturing segment is estimated to account for the largest share of the Continuous Manufacturing market in 2017 owing to the easily available technology for end product manufacturing as compared to API manufacturing by continuous processes.

View Complete Press Releases - https://www.marketsandmarkets.com/PressReleases/continuous-manufacturing.asp